Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma

Clinical trial NCT00119730 · COMPLETED

Trial details

NCT number: NCT00119730
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2005-02-01
Primary completion: 2006-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.